MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1561 to 1580 of 166,322 approvalsPage 79 of 8317

Gemcitabine Hydrochloride for Injection

Approval Number: 国药准字H20253258
Registration: Jan 24, 2025

Ixazomib Citrate Capsules

Approval Number: 国药准字H20253308
Registration: Jan 24, 2025

Trimebutine Maleate Tablets

Approval Number: 国药准字H20253286
Registration: Jan 24, 2025

Flurbiprofen Cataplasms

Approval Number: 国药准字H20253234
Registration: Jan 24, 2025

Amoxicillin Sodium for Injection

Approval Number: 国药准字H20253301
Registration: Jan 24, 2025

Ketorolac Trometamol Injection

Approval Number: 国药准字H20253273
Registration: Jan 24, 2025

Multiple Electrolytes Injection(Ⅱ)

Approval Number: 国药准字H20253260
Registration: Jan 24, 2025

Omeprazole and Sodium Bicarbonate for Suspension(Ⅰ)

Approval Number: 国药准字H20253244
Registration: Jan 24, 2025

Bortezomib for Injection

Approval Number: 国药准字H20253276
Registration: Jan 24, 2025

Cetuximab N01 Injection

Approval Number: 国药准字S20250006
Registration: Jan 24, 2025

Compound Tropicamide Eye Drops

Approval Number: 国药准字H20253245
Registration: Jan 24, 2025

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number: 国药准字H20253231
Registration: Jan 24, 2025

Amorolfine Hydrochloride Liniment

Approval Number: 国药准字H20253230
Registration: Jan 24, 2025

Procaterol Hydrochloride Inhalation Solution

Approval Number: 国药准字H20253327
Registration: Jan 24, 2025

Iron Proteinsuccinylate Oral Solution

Approval Number: 国药准字H20253235
Registration: Jan 24, 2025

Empagliflozin Tablets

Approval Number: 国药准字H20253229
Registration: Jan 24, 2025

Amoxicillin Sodium for Injection

Approval Number: 国药准字H20253299
Registration: Jan 24, 2025

Doxofylline Injection

Approval Number: 国药准字H20253302
Registration: Jan 24, 2025

Levetiracetam Sustained-release Granules

Approval Number: 国药准字H20250005
Registration: Jan 24, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.